Search

TBI-223, a novel oxazolidinone for tuberculosis, is designed to provide improved efficacy and safety compared to linezolid in combination with bedaquiline and pretomanid (BPaL). We aim to optimize the dosing of TBI-223 within the BPaL regimen for enhanced therapeutic outcomes. TBI-223 is investigated in preclinical monotherapy, multidrug therapy, and lesion penetration experiments to describe its efficacy and safety versus linezolid. A translational platform incorporating linezolid and BPaL data from preclinical experiments and 4 clinical trials (NCT00396084, NCT02333799, NCT03086486, NCT00816426) is developed, enabling validation of the framework. TBI-223 preclinical and Phase 1 data (NCT03758612) are applied to the translational framework to predict clinical outcomes and optimize TBI-223 dosing in combination with bedaquiline and pretomanid. Results indicate that daily doses of 1200-2400 mg TBI-223 may achieve efficacy comparable to the BPaL regimen, with >90% of patients predicted to reach culture conversion by two months.

In this research, microorganisms were used to produce Gd2ZnMnO6 NFs in a biological process instead of a chemical method as a nanocatalyst. Considering the capability of the microorganisms to synthesize nanofibrous (NFs) upon exposure to metal ions, microorganisms were employed to produce Gd2ZnMnO6 NFs through a biological process. The utilization of chemical modification to fabricate environmentally friendly heterogeneous nanocatalysts has proven to be highly appealing in the context of synthesizing 3-aryl-2-oxazolidinones using alkenes, carbon dioxide, and amines in an aqueous solution. The role of diverse variables in the creation of 3-aryl-2-oxazolidinones has been thoroughly investigated. Notably, Gd2ZnMnO6 NFs demonstrates remarkable efficiency in the production of 3-aryl-2-oxazolidinones due to its unique morphology. The morphology of Gd2ZnMnO6 NFs contributed to the creation of a desirable outer layer for the creation of 3-aryl-2-oxazolidinones. The findings demonstrated that the utilization of Gd2ZnMnO6 nanofibers positively impacts the effectiveness of the creation of 3-aryl-2-oxazolidinones. This can be attributed to the nanofibers' impressive mechanical and ionic internal characteristics, as well as their exceptional thermal sustainability and persistent colloidal sturdiness. Consequently, employing the host–guest method, the system could be regarded as an exemplary nanocatalyst. A diverse array of olefins was successfully transformed into desirable products, independent of the electronic nature of the substitutes. The involvement of heterogeneous mixtures did not impede the progression of the reaction. Moreover, the 3-aryl-2-oxazolidinones were easily distinguished from the Gd2ZnMnO6 nanofibers, and the medium exhibited the ability to undergo multiple cycles of usage without experiencing a notable decline in their catalytic activity and selectivity. This approach offers notable advantages, including a strong economic capability and the potential to withstand functional groups. Synthesis of biogenic Gd2ZnMnO6 nanofibrous for creation of 3-Aryl-2-oxazolidinones from alkenes, carbon dioxide, and aminesSynthesis of biogenic Gd2ZnMnO6 nanofibrous for creation of 3-Aryl-2-oxazolidinones from alkenes, carbon dioxide, and amines [ABSTRACT FROM AUTHOR]

This perspective discusses bibliography data that has been published since 2018 on the synthesis of oxazolidinones by reacting corresponding aziridines with CO2. The versatility and viability of various procedures have been analyzed by considering the variety of tested substrates as well as experimental conditions and catalytic systems used. Collected data highlights that the reaction can be effectively promoted by several homogeneous and heterogeneous catalytic systems that have been optimized in order to conjugate the process sustainability and productivity with convenient procedural costs. [ABSTRACT FROM AUTHOR]

In this study, a Ni‐based metal‐organic framework (MOF), Ni‐MOF, was synthesized from a mixture of Ni(OAc)2 ⋅ 4H2O, a dicarboxylate, 4,4'‐(1,3,4‐oxadiazole‐2,5‐diyl)dibenzoate (oxdz2−), and a bis(tridentate) ligand, (N,N',N",N"'‐tetrakis(2‐pyridylmethyl)‐1,4‐diaminoxylylene) (tpxn), under ambient conditions using greener solvents in 12 h. The framework was well‐characterized using several analytical techniques. The highly crystalline Ni‐MOF exhibited remarkable polarizing traits with significant uptake of CO2 and water vapor up to 10.53 cm3 g−1 and 290 cm3 g−1, respectively, at 298 K. The isosteric heat of adsorption between Ni‐MOF and CO2 at zero loading was calculated to be 32.43 kJ mol−1. Furthermore, utilizing its CO2‐philic and catalytic features, Ni‐MOF was employed as an excellent heterogeneous catalyst (2.5 mol%) along with very low concentration of TBAB (0.02 mmol) as a co‐catalyst for the synthesis of oxazolidinones via a standard three‐component reaction among an epoxide, a substituted aniline, and carbon dioxide under solvent‐free conditions. A wide range of oxazolidinones including three bioactive derivatives was synthesized using both diverse epoxides and aniline derivatives to demonstrate the substrate scope. The catalyst was proved to be recyclable, reusable, and stable for multiple cycles, without leaching of the metal from it. The mechanistic insights revealed that Ni‐MOF polarizes all three reactants to catalyze the oxazolidinone formation. [ABSTRACT FROM AUTHOR]

The long-term tolerability of linezolid is low because of mitochondrial toxicity, whereas tedizolid may represent a better option for suppressive therapy. We report a first presumed case of tedizolid-associated optic neuropathy after a very prolonged (18-month) intake and believe that screening for optic neuropathy should be considered for patients undergoing tedizolid suppression. [ABSTRACT FROM AUTHOR]

The method for converting epoxy carbamates to oxazolidinones is outlined in this study. This innovative approach combines intermolecular nucleophilic epoxide ring opening with intramolecular acyl substitution in a single step, thereby facilitating rapid conversion. Significantly, this method effectively addresses challenges associated with the use of expensive reagents, harsh reaction conditions, and prolonged reaction times, presenting a more efficient alternative. Demonstrating favorable reactivity across a diverse range of aryl groups, as well as benzyl or tert‐butyl carbamates, the method consistently yields satisfactory results, with oxazolidinone formation ranging from 55 % to 99 % in over 24 examples. The synthesized oxazolidinones, including 5 v–5 x, hold substantial promise as intermediates for the synthesis of crucial synthetic molecules. Furthermore, the versatility of this method is underscored by its successful application in the formation of the 6‐membered ring 1,3‐oxazinan‐2‐one. These findings not only contribute to the advancement of synthetic methodologies but also pave the way for a streamlined synthesis of important pharmaceutical compounds. [ABSTRACT FROM AUTHOR]

[Display omitted] A series of heterogeneous catalysts, designated as POP- n -Pd (where n = 1, 2, 3, or 4), were synthesized by polymerizing a six-membered N -heterocyclic compound with an alkyl substituted group monomer (S1), using divinylbenzene (DVB) as crosslinkers. This process was followed by the incorporation of palladium (Pd) nanoparticles. The impact of the substituted group and the S1 :DVB ratio in the catalysts, together with the reaction conditions, was investigated to assess their influence on the catalytic performance in converting propylamine, carbon dioxide (CO 2) and 4-iodoanisole to oxazolidinones. The POP-1-Pd catalyst, featuring a methyl substituted group and a S1 :DVB ratio of 1:4, exhibited remarkable efficiency, resulting in an excellent yield of 96 % under room temperature and ambient pressure conditions. Furthermore, it has demonstrated wide applicability across a variety of substrates and in the treatment of lime kiln exhaust gas. Additionally, POP-1-Pd can be used in a gram-scale reaction and maintains its performance after six recycles, with no significant decline in yield. The possible catalytic mechanism is proposed as follows: the catalyst's pores adsorb both CO 2 and substrates, creating a high concentration reactant enrichment microenvironment. This facilitates the activation of both CO 2 and substrates by the imidazole moiety and Pd nanoparticles in the catalyst, thereby generating oxazolidinones. [ABSTRACT FROM AUTHOR]

Constructing heterocyclic compounds by chemical fixation of CO2/CS2 as a C1 building block is a promising approach. An efficient and environmentally friendly synthetic approach has been developed using CO2/CS2 to prepare complicated allenyl heterocycles with high yields and diastereoselectivities in a metal-free manner under mild conditions. NIS promoted CO2 fixation and the cyclization reaction by exclusive 1,4-syn-addition of 1,3-enynes rather than 1,2-addition or 3,4-addition, while CS2 participated in unique 1,4-syn-hydrothiolation of 1,3-enynes to afford allenyl heterocycles with different reaction patterns. [ABSTRACT FROM AUTHOR]

The modification on the C5‐side chain in Linezolid analogues development is sporadic owing to the fact that trivial alternation on this position always leads to significant loss of antibacterial activity and in many cases to complete inactivity. The present work focused on constructing the potent yet relatively unexplored C5‐side chain of Linezolid, therefore various C5‐thioethers were synthesized and evaluated for their antibacterial activities. The most potent candidates, hydroxyl thioether (R)‐5 a, (R)‐10 a, and (R)‐5 r which featuring a linear N,S‐acetal amide motif at the C5 side chain, shown strong antibacterial activities with no observable cytotoxicity. [ABSTRACT FROM AUTHOR]

We synthesised a sequence of structurally related copper(II) complexes of Schiff base ligands, 2-[(2-benzylamino-ethylimino)-methyl]-phenol [L1(H)], 2-[(2-benzylamino-ethylimino)-methyl]-4-methyl-phenol [L2(H)], and 2-[(2-benzylamino-ethylimino)-methyl]-4-bromo-phenol [L3(H)]. The complexes were characterized by ATR, UV-vis, EPR, ESI-MS, single crystal XRD, and elemental analyses. Based on the crystal structure, the ligand was coordinated to the copper(II) centre in a tridentate mode through phenolate(oxygen), imine nitrogen and amine nitrogen in an NNO fashion and the azide moiety served as an auxiliary ligand. Furthermore, we have investigated the antimicrobial activities of copper(II) complexes against clinically relevant fungal strains, including Candida albicans, Candida glabrata, and Candida tropicalis, as well as bacteria such as Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA), representing Gram-negative and Gram-positive pathogenic strains. Comparing the activity of complex 2 (128–512 μg mL−1) to complex 3 (64–128 μg mL−1), the latter demonstrated more potent effectiveness against all of the tested fungal strains. The activity of the complexes against MRSA reveals the inhibitory concentrations of 1024 μg mL−1 for 1, 128 μg mL−1 for 2, and 256 μg mL−1 for 3. It is worth mentioning that, at their minimum inhibitory concentrations (MICs), the complexes are not toxic to Galleria mellonella. Furthermore, the spot and broth microdilution assay results were in good agreement with the actual metabolic viability of bacterial and fungal strains, in which the complexes were active while having no effect on the metabolite resazurin. Additionally, in silico studies have been employed to elucidate both non-bonding interactions and the mode of action across protein sequences of experimentally studied microbes. The performance of complexes closely mirrored the reactivity order determined in in vitro studies. The impeding properties of complexes can be due to the dysfunctioning of virulent genes and signalling proteins and also affect the activities of transferase and transcriptase proteins. Overall, the complexes are promising candidates for antimicrobial drug development. We anticipate utilising these molecules for clinical purposes. [ABSTRACT FROM AUTHOR]

The urgent need for novel antibiotics with potent activity against drug‐resistant bacteria is paramount in light of the escalating problem of antibiotic resistance. In this study, we evaluate the antibacterial efficacy of a series of newly designed and synthesized 1H pyrazole‐[3,4‐b]pyridine derivatives against various Gram‐positive and Gram‐negative bacterial strains. Among these derivatives, compound 15 q exhibits comparable antibacterial activity to the established medication Linezolid, demonstrating a minimum inhibitory concentration (MIC) value of 2 μg/mL against both the clinically resistant strain S. aureus M20 and the Gram‐positive bacterium S. aureus ATCC25923. Molecular docking analysis reveals that compound 15 q can interact with nucleotide residue G2505, providing initial insights into its underlying molecular mechanism responsible for its antibacterial activity. Therefore, compound 15 q holds great promise as a lead compound for potential therapeutic interventions against bacterial infections. [ABSTRACT FROM AUTHOR]

Oxazolidinones, such as tedizolid and linezolid, are bacteriostatic antibiotics that inhibit protein synthesis. Based on the findings from animal studies and their mechanism of action, these antibiotics are considered for managing toxic shock caused by clindamycin-resistant Group A Streptococcus (GAS; Streptococcus pyogenes). However, clinical reports on their usage in such cases are limited. Herein, we report a case of a 67-year-old woman with chronic myeloid leukemia who presented with fever, facial swelling, and myalgia. She was diagnosed with cellulitis and empirically treated with meropenem. Blood culture later revealed GAS, and she was diagnosed with streptococcal toxic shock syndrome. The antibiotic regimen was adjusted based on sensitivity results, with clindamycin initially replaced by linezolid and later switched to tedizolid owing to concerns about potential bone marrow suppression. Her condition improved, and she was discharged 15 days after admission. Therefore, tedizolid may be a safer option for managing toxic shock syndrome in patients with comorbidities that include thrombocytopenia. [ABSTRACT FROM AUTHOR]

Objectives: Mastitis is mainly caused by Gram-positive bacteria and usually involves treatment with beta-lactam antibiotics and clindamycin. Oxazolidinones show good results in the treatment of skin and soft tissue infections (SSTIs) due to its pharmacokinetic characteristics. We aimed to describe clinical characteristics and outcomes of patients who received oxazolidinones for the treatment of SSTIs of the mammary tissue. Methods: Retrospective single-centre study of patients with a diagnosis of breast infection who received treatment with oxazolidinones as initial or salvage therapy between September 2016 and November 2022. Patients were identified through the pharmacy database. The primary outcome was clinical cure. Results: Twenty-nine patients received oxazolidinones: 27 received linezolid and 2 tedizolid. Median age was 41 years (IQR 31.0–56.5) and 28 patients were female. Ten patients (35%) had a history of breast cancer, while three (10%) had an immunosuppressive condition. Microbiological isolation was obtained in 24 individuals (83%). Predominant isolations were methicillin-resistant Staphylococcus aureus (8, 28%) and methicillin-susceptible S. aureus (7, 24%). Twenty-four patients (83%) received oxazolidinones as a salvage therapy, with a median duration of 14 days (IQR 10–17). Clinical cure was achieved in 24 patients (83%), while 4 relapsed after a median of 15 days (IQR 4–34). One was lost to follow-up. Three patients (10%) were taking selective serotonin reuptake inhibitors, and one of them concurrently received linezolid for 4 days with no adverse events recorded. Cytopenia during treatment was observed in 2/12 individuals. Oxazolidinones allowed hospital discharge in 11/13 hospitalized patients. Conclusions: Oxazolidinones could be considered as an alternative for treating breast infections. [ABSTRACT FROM AUTHOR]

The rising amount of carbon dioxide in our atmosphere is a concern regarding our environment. This large amount of CO2 can be utilized as a C1 source for chemical fixation. Heterogeneous catalysts like covalent organic frameworks (COFs) have been reported to show excellent CO2 capture ability, which can be used to convert CO2 to various fine chemicals. Here, we synthesized a silver nanoparticle-incorporated TFPNDA COF. This Ag@TFPNDA-COF was characterized by FTIR, PXRD, SEM, TEM, N2-adsorption desorption, TGA, and XPS analyses. Then we tested the catalytic activity of the Ag@TFPNDA-COF. This COF shows excellent CO2 fixation capability in the synthesis of tetronic acids via carboxylative cyclization of propargyl alcohols as well as the formation of oxazolidinones from propargyl alcohols and amines under mild conditions. In addition, the Ag@TFPNDA-COF acted as a heterogeneous catalyst that can be easily separated from the reaction mixture for reuse. Moreover, it showed promising recyclability up to five times in a sustainable route for the production of tetronic acids and oxazolidinones. [ABSTRACT FROM AUTHOR]

Herein, we describe the synthesis and characterisation of four new supramolecular cobalt conjugates of antimicrobial peptides functionalised with terpyridine ligands (L). Peptides were chosen based on the well-established arginine-tryptophan (RW)3 motif, with terpyridine-derivatized lysine (Lys(tpy)) added to the sequence, or replacing tryptophan residues. Self-assembly of the antimicrobial peptides with Co(BF4)2·6H2O formed exclusively CoL2 dimers (for peptides with one tpy ligand each) and Co2L4 metallo-macrocycles (for peptides with two tpy ligands for each peptide), which could be 'locked' by oxidation of Co(+II) to Co(+III) with ammonium ceric nitrate. The Co-peptide complexes were characterised by mass spectrometry and in solution by NMR spectroscopy, including 2D diffusion ordered NMR spectroscopy (DOSY) which confirmed the proposed stoichiometries. The antimicrobial activity of the novel peptides and their metallo-supramolecular assemblies was investigated by determination of their minimal inhibitory concentration (MIC) against a panel of Gram-positive and Gram-negative bacteria. Complexation with cobalt increases the activity of the peptides in almost every case. Most of the new metal–peptide conjugates showed good activity against Gram-positive bacteria, including a multi-resistant S. aureus strain and the opportunistic pathogenic yeast C. albicans (down to 7 μmol l−1 for the most active Co2L4 derivate), a value that is increased five-fold compared to the lysine-derivatized peptide ligand alone. Interestingly, conjugates of the CoL2 type also showed decent activity against Gram-negative bacteria including the WHO-flagged problematic A. baumannii strain (down to 18 μmol l−1 for the most active derivative). [ABSTRACT FROM AUTHOR]

Background and aim. Infections caused by pathogenic bacteria increase patient morbidity and mortality and significantly raise treatment costs. The use of silver nanoparticles as an alternative treatment for S aureus, E coli, MRSA, E faecalis, K pneumoniae and P aeruginosa indicates their antibacterial effect and prompts medical research to consider the next generation of antibacterial drugs that could change antibiotic therapy. By combining silver nanoparticles with different classes of antibiotics, the antibacterial effect is evidenced by increased values of the inhibition zone compared to the values obtained for some antibiotics commonly used in the treatment of bacterial infections. This study focuses on comparing the antibacterial activity of antibiotics versus antibiotics combined with silver nanoparticles against various bacteria, by comparing inhibition zones obtained for both. We aim to prove that the size of the inhibition zone for antibiotics combined with silver nanoparticles is greater, thus confirming the improved antibacterial effect. Metods. In this study we tested the antibacterial activity of solutions of silver nanoparticles alone or in combination with different antibiotics. We used standard bacterial strains, ATCC, both Gram positive bacteria Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212, as well as Gram negative bacteria Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, but also on clinical isolates: a strain MRSA (Methicillin Resistant Staphylococcus aureus) and a PDR strain (pan drug resistant) of Klebsiella pneumoniae. Bacterial identification was performed using Vitek MS analyzer (bioMerieux). Antibiotic susceptibility determination was performed with VITEK2 COMPACT SYSTEM (bio Merieux, Inc Durham NC) with ready to use VITEK AST cards. The interpretation of the results was done in compliance with EUCAST 2023-2024 standards. Testing was performed for several classes of antibiotics, silver nanoparticle solutions in 2 concentrations (10 μg/mL and 100 μg/mL) and for combinations of antibiotics with silver nanoparticle solutions. The diameter of the inhibition zone (ZOI) for silver nanoparticles, antibiotics and silver nanoparticles combined with antibiotic against each bacterium was expressed in millimeters. The Kirby-Bauer diskdiffusion method, in accordance with current EUCAST standards, was used to analyze the antibacterial effect of antibiotics, silver nanoparticles, and antibiotics combined with silver nanoparticles at biocompatible doses of 10 and 100 μg/mL. The experiments were conducted in triplicate, and the results were almost identical. Results. The results of this study show that the silver nanoparticles displayed antibacterial activity, proven by the appearance of the inhibition zone, in various sizes, for all bacteria studied. The antibiotic classes tested were beta-lactamins, first, second, third and fourth generation cephalosporins, macrolides, fluoroquinolones, lincosamides, aminoglycosides, glycopeptides, tetracyclines, oxazolidinones, sulfonamides, rifamycins, amphenicols. Testing S aureus ATCC 29213, the highest zone of inhibition was demonstrated for cephalosporins (32.6667 ± 0.701 mm), macrolides (31.6667 ± 0.701 mm, and lincosamides (29.6667 ± 0.701 mm). Testing MRSA (internal code GR0333), the highest zone of inhibition for combination of silver nanoparticles and antibiotics was demonstrated for fluoroquinolones (36.3333 ± 0.701 mm), lincosamides (32.3333 ± 0.701 mm), Fusid acid (32.3333 ± 0.701 mm) and aminoglicosides (31.3333 ± 0.701 mm). Testing E coli ATCC 25922 the highest zone of inhibition was for Fosfomycine, 39 mm and for E faecalis ATCC 29212 for aminoglicosides was 19 mm. For K pneumoniae (internal code GQ8575) the inhibition zone for silver nanoparticles 100 µg/mL was 12.3333 ± 0.701 mm and for P aeruginosa ATCC 27253 was 16 ± 1.214 mm. Conclusions. The use of metallic nanoparticles, especially silver ones, as antimicrobial agents with definite bactericidal activity has led medical specialists to consider this new treatment which may change antibacterial therapy. Studies of in vitro combinations between silver nanoparticles and different classes of antibiotics represent a highly efficient and effective new antibacterial treatment against multidrug-resistant bacteria. To avoid the problem of antimicrobial resistance associated with conventional antibiotics, it is necessary to understand the adaptive mechanisms of bacteria under the action of metal nanoparticles, which could be exploited in future studies. Further in vitro and in vivo studies that would assess specify the biocompatibility and toxicity of silver nanoparticles will make these super nanomaterials the medicines of the future. [ABSTRACT FROM AUTHOR]

The capture and conversion of carbon dioxide (CO2) into valuable chemical products under mild conditions is an important and challenging approach for contemporary industry. Carboxylic acid ligands are widely used in the development of functionalized metal organic framework materials due to their excellent stability. Herein, a novel mixed-metal organic framework Cu-TCPP(Fe) was assembled from iron-(Fe)-porphyrin ligands, which can efficiently catalyze the reaction of propargylic amines and CO2 to synthesize 2-oxazolidinones. [ABSTRACT FROM AUTHOR]

In this study, we present the re‐synthesis of a series of twelve bis‐ureido‐substituted benzenesulfonamides, focusing on their potential as antibacterial, anticholinesterase, and cytotoxic agents. First, the antibacterial assessment of these compounds indicated varying activity levels across different bacterial strains, with S. aureus displaying resistance to all compounds, while compounds 9 and 11 exhibited promise against E. faecalis with a MIC value of 31.25 μg/mL. Additionally, P. aeruginosa showed resistance to compounds containing 4‐aminobenzene sulfonamides, whereas derivatives such as (8–11) and compound 19 displayed notable activity against E. coli, comparable to Ampicillin. Second, their anticholinesterase activities were examined, with a focus on their potential role in addressing neurological disorders, particularly Alzheimer′s disease. The findings indicated that all synthesized compounds showed a significant inhibitory effect on both AChE and BChE enzymes. Compound 11 demonstrated the most effective inhibition on the AChE enzyme with an IC50 value of 0.2160±0.09 nM, while compound 18 exhibited the most potent inhibition on the BChE enzyme with an IC50 value of 0.2257±0.06 nM. Finally, cytotoxicity studies were conducted across various cell lines, including breast, lung, and prostate cancer cells and normal cells. The results revealed that compound 12 emerged as the most potent tested compound against breast cancer cells with no cytotoxic effect on CRL‐4010 normal breast epithelial cells. The research presented here not only highlights the multifaceted pharmacological potential of bis‐ureido‐substituted benzenesulfonamides, but also indicates their potential as versatile compounds for antibacterial, anticholinesterase, and cytotoxicity applications, opening up new avenues for drug discovery and development. [ABSTRACT FROM AUTHOR]

Herein, we report the synthesis, crystal structure, and antibacterial activity of a new Ni(II) complex derived from the N, O donor (E)-2,4-dibromo-6-(2-(1-phenylethylimino) ethyl) phenol ligand. Both the ligand and the complex were characterized by employing FT-IR, UV-Visible, and fluorescence spectroscopy as well as single-crystal X-ray diffraction studies. The crystallographic results reveal that the complex crystalizes in the monoclinic unit cell with the space group C2, and the coordination environment around the Ni centre consists of NiN2O2 donor sites exhibiting a highly distorted tetrahedral geometry. The oxidative assay of DPPH (α,α-diphenyl-β-picrylhydrazyl) was used for evaluating the radical scavenging activity or antioxidant properties of the complex in terms of IC50 values (50% inhibition); it was observed that the complex showed reasonable antioxidant activities with ascorbic acid (AA) as the standard. Detailed interaction studies with calf thymus (CT) DNA and bovine serum albumin (BSA) were performed through various spectroscopic and theoretical approaches and indicated that the complex has promising binding capability with both the systems. Comprehensive biological studies were performed and showed that the complex exhibits notable antibacterial activity against Gram-positive methicillin-resistant Staphylococcus aureus (MRSA) by interfering with its cell wall integrity. Microscopic imaging confirmed cellular abnormalities, such as alterations in the cell shape, size, and quantity. Molecular docking analyses also provided insights into the activities of the complex. In contrast, the complex displayed minimal growth inhibition properties against Gram-negative Klebsiella pneumoniae (KP) even at higher complex concentration, indicating that the specific inhibition activity of the complex is only against Gram-positive MRSA. Moreover, based on optical density readings, the results demonstrated that the complex exhibited effective antibacterial activity against MRSA with an MIC value between 34 and 36 μg ml−1, whereas the MIC value of standard cefoxitin is >70 μg ml−1. Thus, our complex demonstrated better antibacterial activity than the conventional antibiotic. [ABSTRACT FROM AUTHOR]

We described the protein engineering of the halohydrin dehalogenase HheG to enhance its R enantioselectivity for the synthesis of chiral 4‐aryloxazolidinones via α‐regioselective ring‐opening of aryl epoxides with cyanate. Additionally, we achieved the inversion of its regioselectivity and enantioselectivity, resulting in a HheG variant tailored for the synthesis of chiral 5‐aryloxazolidinones via β‐regioselective and S‐enantioselective ring‐opening of aryl epoxides with cyanate. Leveraging these engineered mutants, we developed a biocatalytic platform capable of synthesis of both chiral 4‐aryloxazolidinones (up to 47% yield, 98% ee, and 99% regioselectivity) and chiral 5‐aryloxazolidinones (up to 46% yield, >99% ee, and 98% regioselectivity). Furthermore, a collaborative approach utilizing two regio‐ and enantioselective HheG mutants has been demonstrated to enable the simultaneous synthesis of chiral 4‐aryloxazolidinones and chiral 5‐aryloxazolidinones. [ABSTRACT FROM AUTHOR]

• Endophytic fungi- Ascochyta medicaginicola SK16, Phoma sp. SK5 has been isolated from African Club moss- S. kraussiana (Kunze) A., collected from Darjeeling Himalayan hills. • Ethyl acetate (EA) extract of secondary metabolites of SK16 exhibited broad spectrum microbicidal activity against seventeen pathogens including Methicillin-resistant Staphylococcus aureus (MRSA), and C. albicans. • It inhibited pathogens' key metabolic enzymes, caused leakage of major macromolecules, act synergistically with antibiotics/antifungals, blocked biofilm formation, and also stopped the yeast to hyphal transition in case C. albicans. • EA extracts of SK5 exhibited free radical scavenging activity against DPPH, ABTS, and H 2 O 2 , in-vitro antioxidative activity towards peritoneal macrophage cells, and also were cytotoxic against cancer cell lines. • Bioactive compounds were recorded by GC-MS analysis. The search for potent natural compounds from plant and microbial sources is increasing logarithmically to combat various types of health issues of which multidrug-resistant microbes and problems related to oxidative stress are the prime ones. Novel secondary metabolites from endophytes have always been potent alternatives to contemporary antimicrobials and antioxidants. The present study shows that two potent endophytic fungal isolates Ascochyta medicaginicola SK16 and Phomopsis sp. SK5 synthesises non-proteinaceous, thermostable secondary metabolites with broad-spectrum antimicrobial, antioxidative, and cytotoxic activity. Bioassay-guided fractionation revealed that the Ethyl acetate (EA) extract of the cell-free culture extract (CFCE) of SK5 and SK16 constitutes ten and eleven secondary metabolites of which 2,4, -di tert butyl phenol, aziridine- 1,2-amino ethyl, actinobolin, bactobolin, azulene, menthyl acetate, phenol, p-[2-(methylamino)ethyl], and imidazole components were significant. SK16 exhibited strong antimicrobial activity against seventeen pathogens including Methicillin-resistant Staphylococcus aureus (MRSA), and C. albicans with a minimum microbicidal concentration of 100- 400 µg mL−1. These metabolites disrupt the microbial cell membranes causing lethal leakage of biomacromolecules- nucleic acid, protein, and potassium ions. Enzymes involved in the EMP pathway, TCA cycle, and gluconeogenesis were also blocked. Both the biofilm formation and transition of Candida cells from the yeast-to-hyphal form were inhibited. SK5 metabolites are potent radical scavengers with an IC 50 of 34.25 ± 0.87 – 195.21 ± 5.73 µg mL−1 against DPPH, ABTS, FRAP, and H 2 O 2 free radical generators and significantly increased antioxidant parameters in treated peritoneal macrophage cells of male Wistar rats. Also, SK5 metabolites were cytotoxic against breast (T47D), pancreatic (MIA Paca-2), lung (A549) and colon (HCT-116) cancer cells. The present findings suggest that metabolites from endophytes of African club moss hold potent pharmaceutical utilities. [ABSTRACT FROM AUTHOR]

Multidrug-resistant tuberculosis (MDR-TB) is a global health concern. Standard treatment involves the use of linezolid, a repurposed oxazolidinone. It is associated with severe adverse effects, including myelosuppression and mitochondrial toxicity. As such, it is imperative to identify novel alternatives that are better tolerated but equally or more effective. Therefore, this review aims to identify and explore the novel alternative oxazolidinones to potentially replace linezolid in the management of TB. The keywords tuberculosis and oxazolidinones were searched in PubMed to identify eligible compounds. The individual drug compounds were then searched with the term tuberculosis to identify the relevant in vitro, in vivo and clinical studies. The search identified sutezolid, tedizolid, delpazolid, eperezolid, radezolid, contezolid, posizolid and TBI-223, in addition to linezolid. An additional search resulted in 32 preclinical and 21 clinical studies. All novel oxazolidinones except posizolid and eperezolid resulted in positive preclinical outcomes. Sutezolid and delpazolid completed early phase 2 clinical studies with better safety and equal or superior efficacy. Linezolid is expected to continue as the mainstay therapy, with renewed interest in drug monitoring. Sutezolid, tedizolid, delpazolid and TBI-223 displayed promising preliminary results. Further clinical studies would be required to assess the safety profiles and optimize the dosing regimens. [ABSTRACT FROM AUTHOR]

Flavonoids are an abundant class of naturally occurring compounds with broad biological activities, but their limited abundance in nature restricts their use in medicines and food additives. Here we present the synthesis and determination of the antibacterial and antioxidant activities of twenty-two structurally related flavonoids (five of which are new) by scientifically validated methods. Flavanones (FV1–FV11) had low inhibitory activity against the bacterial growth of MRSA 97-7. However, FV2 (C5,7,3′,4′ = OH) and FV6 (C5,7 = OH; C4′ = SCH3) had excellent bacterial growth inhibitory activity against Gram-negative E. coli (MIC = 25 µg/mL for both), while Chloramphenicol (MIC = 25 µg/mL) and FV1 (C5,7,3′ = OCH3; 4′ = OH) showed inhibitory activity against Gram-positive L. monocytogenes (MIC = 25 µg/mL). From the flavone series (FO1–FO11), FO2 (C5,7,3′,4′ = OH), FO3 (C5,7,4′ = OH; 3′ = OCH3), and FO5 (C5,7,4′ = OH) showed good inhibitory activity against Gram-positive MRSA 97-7 (MIC = 50, 12, and 50 µg/mL, respectively), with FO3 being more active than the positive control Vancomycin (MIC = 25 µg/mL). FO10 (C5,7= OH; 4′ = OCH3) showed high inhibitory activity against E. coli and L. monocytogenes (MIC = 25 and 15 µg/mL, respectively). These data add significantly to our knowledge of the structural requirements to combat these human pathogens. The positions and number of hydroxyl groups were key to the antibacterial and antioxidant activities. [ABSTRACT FROM AUTHOR]

This paper reports the design, synthesis, and antibacterial activity study of pleuromutilin derivatives with 2‐methyl‐4‐nitroaniline and 2‐methoxy‐4‐nitroaniline side chains at the C22 position. The structures of the new compounds were characterized by 1H‐NMR, 13C‐NMR and HRMS. The inhibitory activity of the compounds against MSSA, pyogeniccoccus, streptococcus, and MRSA strains was determined using the micro broth dilution method. The results showed that the compounds exhibited certain activity against Gram‐positive bacteria, among which compounds A8a, A8b, A8c, A8d, and A7 demonstrated superior antibacterial activity against MSSA, MRSA, and pyogeniccoccus compared to tiamulin, although the derivatives showed lower antibacterial activity against streptococcus compared to the control drug. Based on the favorable in vitro activity of A8c, the time‐kill kinetics against MRSA were evaluated, revealing that compound A8c could inhibit bacterial proliferation in a concentration‐dependent manner. [ABSTRACT FROM AUTHOR]

Antimicrobial resistance poses a serious threat to human health worldwide and its incidence continues to increase owing to the overuse of antibiotics and other factors. Macrolide antibiotics such as erythromycin (EM) have immunomodulatory effects in addition to their antibacterial activity. Long-term, low-dose administration of macrolides has shown clinical benefits in treating non-infectious inflammatory respiratory diseases. However, this practice may also increase the emergence of drug-resistant bacteria. In this study, we synthesized a series of EM derivatives, and screened them for two criteria: (i) lack of antibacterial activity and (ii) ability to suppress tumor necrosis factor-α (TNF-α) production in THP-1 cells stimulated with lipopolysaccharide. Among the 37 synthesized derivatives, we identified a novel 12-membered ring macrolide EM982 that lacked antibacterial activity against Staphylococcus aureus and suppressed the production of TNF-α and other cytokines. The effects of EM982 on Toll-like receptor 4 (TLR4) signaling were analyzed using a reporter assay and Western blotting. The reporter assay showed that EM982 suppressed the activation of transcription factors, NF-kB and/or activator protein 1 (AP-1), in HEK293 cells expressing human TLR4. Western blotting showed that EM982 inhibited the phosphorylation of both IkB kinase (IKK) β and IkBα, which function upstream of NF-kB, whereas it did not affect the phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and c-Jun N-terminal kinase, which act upstream of AP-1. These results suggest that EM982 suppresses cytokine production by inhibiting phosphorylation of IKKβ and IkBα, resulting in the inactivation of NF-kB. [ABSTRACT FROM AUTHOR]

[Display omitted] [ABSTRACT FROM AUTHOR]

A method for the asymmetric synthesis of phthalides containing a stereogenic γ‐carbon has been described. The protocol, based on the arylogous Michael addition to chiral alkenoyl oxazolidinones catalyzed by a crown ether under phase‐transfer conditions does not require anhydrous conditions and uses commercially available materials. A complete syn‐stereocontrol is achieved and facial diastereoselectivities are moderate to excellent (62:38 to 99:1 dr). Purification of the major diastereomer by chromatography and selective cleavage of the chiral auxiliary affords enantiopure Michael products. The protocol has been applied to the formal synthesis of escitalopram. [ABSTRACT FROM AUTHOR]

Using density functional theory (DFT), we treat the reaction of coupling of CO2 with aziridine in gas phase, in the presence of water and of a green catalyst (NaBr). Computations show that, in gas phase, this ring‐opening conversions to oxazolidinones initiates by coordinating a CO2 molecule to the nitrogen atom of the aziridine. Then, a nucleophilic interaction between one oxygen atom of the coordinated CO2 and the carbon atom of the aziridine occurs. For methyl substituted aziridine, two pathways are proposed leading either to 4‐oxazolidinone or to 5‐oxazolidinone. Besides, we show that the activation energy of this reaction reduces in aqueous solution, in the presence of a water molecule explicitly or NaBr catalyst. In addition, the corresponding reaction mechanisms and regioselectivity associated with this ring‐opening conversions to oxazolidinones, in the presence of carbon dioxide are found to be influenced by solvent and catalyst. The present findings should allow better designing regioisomer oxazolidinones relevant for organic chemistry, medicinal and pharmacological applications. [ABSTRACT FROM AUTHOR]

Background: This study focuses on the development of a novel and environmentally friendly synthetic methodology for the production of a series of six 4-benzylidene-2-phenyloxazol- 5(4H)-one derivative (M1-M6). The approach involves a one-pot procedure utilizing hippuric acid, fused sodium acetate and various substituted aromatic aldehydes in the presence of acetic anhydride. Purpose: The primary objective is to explore the potential antioxidant properties of the synthesized compounds and contribute to the understanding of azlactones as promising antioxidants. The study integrates experimental synthesis with in silico methodologies to comprehensively characterize the chemical and biological properties of the derivatives. Materials and Methods: The synthesis process employed a combination of hippuric acid, fused sodium acetate and substituted aromatic aldehydes in a one-pot procedure. The chemical structures of the derivatives were characterized and validated through in silico techniques, including docking studies, drug-likeness assessments, bioactivity predictions, ADME profiling and toxicity evaluations. Results: The in silico analyses provided insights into the molecular interactions, pharmacokinetic properties and safety profiles of the synthesized compounds. In vitro antioxidant potential was systematically investigated using the DPPH method, with compounds M3 and M5 demonstrating significant antioxidant activity at a concentration 40 µg/ mL showing (88% inhibition) and (85.7% inhibition) respectively, surpassing ascorbic acid as the reference standard. Conclusion: This study successfully explores azlactones as potential antioxidants, combining experimental synthesis and in silico methodologies to characterize the chemical and biological properties of the synthesized derivatives. The notable antioxidant activity of compounds M3 and M5 positions them as promising candidates for further investigation. The findings establish a foundation for future research and development of these compounds in potential antioxidant-related therapeutic interventions. [ABSTRACT FROM AUTHOR]

Growing resistance to antimicrobials, combined with pathogens that form biofilms, presents significant challenges in healthcare. Modifying current antimicrobial agents is an economical approach to developing novel molecules that could exhibit biological activity. Thus, five sulfanilamide Schiff bases were synthesized under microwave irradiation and characterized spectroscopically and in silico. They were evaluated for their antimicrobial and antibiofilm activities against both Gram-positive and Gram-negative bacterial strains. Their cytotoxic potential against two cancer cell lines was also determined. Gram-positive bacteria were susceptible to the action of these compounds. Derivatives 1b and 1d inhibited S. aureus's growth (MIC from 0.014 mg/mL) and biofilm (IC from 0.029 mg/mL), while compound 1e was active against E. faecalis's planktonic and sessile forms. Two compounds significantly reduced cell viability at 5 μg/mL after 24 h of exposure (1d—HT-29 colorectal adenocarcinoma cells, 1c—LN229 glioblastoma cells). A docking study revealed the increased binding affinities of these derivatives compared to sulfanilamide. Hence, these Schiff bases exhibited higher activity compared to their parent drug, with halogen groups playing a crucial role in both their antimicrobial and cytotoxic effects. [ABSTRACT FROM AUTHOR]

A type of Al-MCM-41 supported dual imidazolium ionic liquids were constructed and efficiently used as catalysts for the synthesis of 2-oxazolidinones from epoxides, amines, and CO2. The influence of the different catalysts and reaction parameters on the catalytic behaviours was investigated. Al-MCM-41@ILTiCl5 was identified as the most excellent catalyst because it could efficiently promote the three-component cycloaddition of CO2, epoxide, and amines to form the corresponding 2-oxazolidinones in high to excellent yields (84∼96%) with excellent selectivities (98∼99.7%). In addition, the recovery and reuse performances of Al-MCM-41@ILTiCl5 were examined. The catalyst could be recovered by simple filtration and reused six times without a change in the catalytic activity. Green reaction conditions, operational simplicity, feasibility, and sustainability of the functionalized catalyst are the main highlights of the present protocol. [ABSTRACT FROM AUTHOR]

An asymmetric transfer hydrogenation of 2‐oxazolones in the presence of a chiral diamine ruthenium catalyst with potassium formate as a hydrogen source and potassium carbonate as an additive in 2,2,2‐trifluoroethanol is described. A series of chiral 2‐oxazolidinones were obtained with 29%–95% yields and 86%–>99% ee's. Furthermore, gram‐scale synthesis of chiral 2‐oxazolidinone and its downstream derivatizations demonstrate the practicality of this method. [ABSTRACT FROM AUTHOR]

The pharmacological importance of quinoxaline derivatives in antibacterial research is well recognized. This study focuses on the synthesis of new 2,3‐dichloroquinoxaline derivatives containing thioether/ether groups to explore their potential as potent antibacterial agents against various pathogenic bacteria. Most of the compounds exhibited significant antibacterial properties comparable to the standard drug chlorhexidine (CHX). The derivatives of 2‐chloro‐3‐(arylthiol)quinoxaline demonstrated efficacy against Escherichia coli with minimum inhibitory concentrations (MIC) of 2.5 mg/mL and minimum bactericidal concentrations (MBC) of 2.5 to 5.0 mg/mL. These derivatives also showed similar sensitivity to Bacillus pumilus. In addition, molecular docking simulations were performed to investigate the interaction between the synthesized compounds and the DNA gyrase protein (PDB ID: 1KZN), a target for antibiotics. Among the synthesized compounds, 2,3‐bis(3‐nitrophenoxy)quinoxaline exhibited the most favourable docking score of −8.36 kcal/mol, with a binding affinity comparable to that of the reference ligand clorobiocin (−9.3 kcal/mol). [ABSTRACT FROM AUTHOR]

In this contribution, we describe a straightforward and efficient synthesis of oxazolidin‐2‐ones through a Cu(I)‐catalyzed four‐component coupling of amines, aldehydes, terminal alkynes, and CO2 via carboxylative cyclization of propargylamine intermediates. This strategy enables the selective synthesis of a variety of (Z)‐5‐alkylidene‐oxazolidin‐2‐ones substituted in positions 3, 4 and 5 of the heterocyclic core with a variety of functional groups, well‐tolerated in terms of scope. A mechanistic study was carried out monitoring the process in solution by different techniques (operando FTIR, multi‐nuclear NMR), with the aim of identifying the intermediates, both organic compounds and Cu(I) coordination complexes, which showed the plausible multi‐metallic nature of the catalytic intermediates (identified by X‐ray diffraction analyses on monocrystal). [ABSTRACT FROM AUTHOR]

The non‐noble‐metal catalysed‐multicomponent reactions between flue gas CO2 and cheap industrial raw stocks into high value‐added fine chemicals is a promising manner for the ideal CO2 utilization route. To achieve this, the key fundamental challenge is the rational development of highly efficient and facile reaction pathway while establishing compatible catalytic system. Herein, through the stepwise solvent‐assisted linker installation, post‐synthetic fluorination and metalation, we report the construction of a series of perfluoroalkyl‐decorated noble‐metal‐free metal–organic frameworks (MOFs) PCN‐(BPY‐CuI)‐(TPDC‐Fx) [BPY=2,2′‐bipyridine‐5,5′‐dicarboxylate, TPDC‐NH2=2′‐amino‐[1,1′:4′,1′′‐terphenyl]‐4,4′′‐dicarboxylic acid] that can catalyze the one‐pot four‐component reaction between alkyne, aldehyde, amine and flue gas CO2 for the preparation of 2‐oxazolidinones. Such assembly endows the MOFs with superhydrophobic microenvironment, superior water resistance and highly stable catalytic site, leading to 21 times higher turnover numbers than that of homogeneous counterparts. Mechanism investigation implied that the substrates can be efficiently enriched by the MOF wall and then the adsorbed amine species act as an extrinsic binding site towards dilute CO2 through their strong preferential formation to carbamate acid. Moreover, density functional theory calculations suggest the tetrahedral geometry of Cu in MOF offers special resistance towards amine poisoning, thus maintaining its high efficiency during the catalytic process. [ABSTRACT FROM AUTHOR]

The non‐noble‐metal catalysed‐multicomponent reactions between flue gas CO2 and cheap industrial raw stocks into high value‐added fine chemicals is a promising manner for the ideal CO2 utilization route. To achieve this, the key fundamental challenge is the rational development of highly efficient and facile reaction pathway while establishing compatible catalytic system. Herein, through the stepwise solvent‐assisted linker installation, post‐synthetic fluorination and metalation, we report the construction of a series of perfluoroalkyl‐decorated noble‐metal‐free metal–organic frameworks (MOFs) PCN‐(BPY‐CuI)‐(TPDC‐Fx) [BPY=2,2′‐bipyridine‐5,5′‐dicarboxylate, TPDC‐NH2=2′‐amino‐[1,1′:4′,1′′‐terphenyl]‐4,4′′‐dicarboxylic acid] that can catalyze the one‐pot four‐component reaction between alkyne, aldehyde, amine and flue gas CO2 for the preparation of 2‐oxazolidinones. Such assembly endows the MOFs with superhydrophobic microenvironment, superior water resistance and highly stable catalytic site, leading to 21 times higher turnover numbers than that of homogeneous counterparts. Mechanism investigation implied that the substrates can be efficiently enriched by the MOF wall and then the adsorbed amine species act as an extrinsic binding site towards dilute CO2 through their strong preferential formation to carbamate acid. Moreover, density functional theory calculations suggest the tetrahedral geometry of Cu in MOF offers special resistance towards amine poisoning, thus maintaining its high efficiency during the catalytic process. [ABSTRACT FROM AUTHOR]

The non‐noble‐metal catalysed‐multicomponent reactions between flue gas CO2 and cheap industrial raw stocks into high value‐added fine chemicals is a promising manner for the ideal CO2 utilization route. To achieve this, the key fundamental challenge is the rational development of highly efficient and facile reaction pathway while establishing compatible catalytic system. Herein, through the stepwise solvent‐assisted linker installation, post‐synthetic fluorination and metalation, we report the construction of a series of perfluoroalkyl‐decorated noble‐metal‐free metal–organic frameworks (MOFs) PCN‐(BPY‐CuI)‐(TPDC‐Fx) [BPY=2,2′‐bipyridine‐5,5′‐dicarboxylate, TPDC‐NH2=2′‐amino‐[1,1′:4′,1′′‐terphenyl]‐4,4′′‐dicarboxylic acid] that can catalyze the one‐pot four‐component reaction between alkyne, aldehyde, amine and flue gas CO2 for the preparation of 2‐oxazolidinones. Such assembly endows the MOFs with superhydrophobic microenvironment, superior water resistance and highly stable catalytic site, leading to 21 times higher turnover numbers than that of homogeneous counterparts. Mechanism investigation implied that the substrates can be efficiently enriched by the MOF wall and then the adsorbed amine species act as an extrinsic binding site towards dilute CO2 through their strong preferential formation to carbamate acid. Moreover, density functional theory calculations suggest the tetrahedral geometry of Cu in MOF offers special resistance towards amine poisoning, thus maintaining its high efficiency during the catalytic process. [ABSTRACT FROM AUTHOR]

The non‐noble‐metal catalysed‐multicomponent reactions between flue gas CO2 and cheap industrial raw stocks into high value‐added fine chemicals is a promising manner for the ideal CO2 utilization route. To achieve this, the key fundamental challenge is the rational development of highly efficient and facile reaction pathway while establishing compatible catalytic system. Herein, through the stepwise solvent‐assisted linker installation, post‐synthetic fluorination and metalation, we report the construction of a series of perfluoroalkyl‐decorated noble‐metal‐free metal–organic frameworks (MOFs) PCN‐(BPY‐CuI)‐(TPDC‐Fx) [BPY=2,2′‐bipyridine‐5,5′‐dicarboxylate, TPDC‐NH2=2′‐amino‐[1,1′:4′,1′′‐terphenyl]‐4,4′′‐dicarboxylic acid] that can catalyze the one‐pot four‐component reaction between alkyne, aldehyde, amine and flue gas CO2 for the preparation of 2‐oxazolidinones. Such assembly endows the MOFs with superhydrophobic microenvironment, superior water resistance and highly stable catalytic site, leading to 21 times higher turnover numbers than that of homogeneous counterparts. Mechanism investigation implied that the substrates can be efficiently enriched by the MOF wall and then the adsorbed amine species act as an extrinsic binding site towards dilute CO2 through their strong preferential formation to carbamate acid. Moreover, density functional theory calculations suggest the tetrahedral geometry of Cu in MOF offers special resistance towards amine poisoning, thus maintaining its high efficiency during the catalytic process. [ABSTRACT FROM AUTHOR]

Although the asymmetric catalysis has made a spurt of progress, the use of chiral auxiliaries remains crucial in asymmetric synthesis due to both the reliability and versatility of the methods, and the predictability of stereochemistry of the reactions. Up to date, Evans' chiral non‐racemic oxazolidinone‐based asymmetric synthetic methodology is still widely used in asymmetric synthesis. More importantly, the Evans asymmetric synthetic methodology turned out to be a fruitful source of inspiration for the development of related asymmetric synthetic methodologies. However, although reviews on the application of Evans' asymmetric synthetic methodology in both organic synthesis and medicinal chemistry continually to appear in the literature, a comprehensive review dedicating to the extensions of Evans' chiral non‐racemic oxazolidinone‐based asymmetric methodology remains elusive. In this review, we summarize the extensions of the Evans asymmetric methodology, which cover: (1) the modification of the chiral oxazolidinone auxiliaries; (2) the extension of the Evans' asymmetric aldol reaction from Evans' syn‐aldol to other diastereomeric aldol adducts; (3) the extension of the asymmetric reaction types; (4) the extension of chiral imide‐type substrates to N‐alkenyl, N‐allenenyl and N‐alkynyl oxazolidinones; (5) the achiral oxazolidinone‐based asymmetric catalysis; (6) the catalytic transformation of Evans' products; and (7) the straightforward transformations of Evans' chiral products to other classes of compounds than the chiral carboxylic acids, esters, alcohols, and Weinreb amides. [ABSTRACT FROM AUTHOR]